It was not transitioned to the Food and Drug Regulations when the interim order expired on September 16, 2021. The AstraZeneca Vaxzevria® COVID-19 vaccine is authorized for use in Canada under the Food and Drug Regulations. Vaccine review, approval and monitoring.The vaccine is approved for people who are 18 years of age and older. Its safety and effectiveness in people younger than 18 years of age have not yet been established. List of i doser doses and descriptions trial#Ĭlinical trials showed that beginning 2 weeks after the second dose, the AstraZeneca Vaxzevria® COVID-19 vaccine was 74% effective in protecting trial participants against COVID-19. This vaccine requires 2 doses for maximum protection. The dosing schedule approved by Health Canada is to give the 2 doses 4 to 12 weeks apart, based on evidence from clinical trials. Your province or territory decides when people receive their first and second doses of the vaccine.
These decisions are based on public health recommendations and the latest evidence. List of i doser doses and descriptions trial#.
